A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice

Cheng Wei Lai, Hsiao Ling Chen, Min Yu Tu, Wei Yu Lin, Theresa Röhrig, Shang-Hsun Yang, Ying Wei Lan, Kowit Yu Chong, Chuan Mu Chen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The AKR1A1 protein is a member of the aldo-keto reductase superfamily that is responsible for the conversion of D-glucuronate to L-gulonate in the ascorbic acid (vitamin C) synthesis pathway. In a pCAG-eGFP transgenic mouse line that was produced by pronuclear microinjection, the integration of the transgene resulted in a 30-kb genomic DNA deletion, including the Akr1A1 gene, and thus caused the knockout (KO) of the Akr1A1 gene and targeting of the eGFP gene. The Akr1A1 KO mice (Akr1A1eGFP/eGFP) exhibited insufficient serum ascorbic acid levels, abnormal bone development and osteoporosis. Using micro-CT analysis, the results showed that the microarchitecture of the 12-week-old Akr1A1eGFP/eGFP mouse femur was shorter in length and exhibited less cortical bone thickness, enlargement of the bone marrow cavity and a complete loss of the trabecular bone in the distal femur. The femoral head and neck of the proximal femur also showed a severe loss of bone mass. Based on the decreased levels of serum osteocalcin and osteoblast activity in the Akr1A1eGFP/ eGFP mice, the osteoporosis might be caused by impaired bone formation. In addition, administration of ascorbic acid to the Akr1A1eGFP/eGFP mice significantly prevented the condition of osteoporotic femurs and increased bone formation. Therefore, through ascorbic acid administration, the Akr1A1 KO mice exhibited controllable osteoporosis and may serve as a novel model for osteoporotic research.

Original languageEnglish
Pages (from-to)7357-7369
Number of pages13
JournalOncotarget
Volume8
Issue number5
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Ascorbic Acid Deficiency
Gene Knockout Techniques
Knockout Mice
Ascorbic Acid
Osteoporosis
Femur
Osteogenesis
Glucuronic Acid
Gene Targeting
Bone Development
Femur Neck
Osteocalcin
Microinjections
Serum
Osteoblasts
Transgenes
Transgenic Mice
Genes
Bone Marrow
Bone and Bones

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Lai, C. W., Chen, H. L., Tu, M. Y., Lin, W. Y., Röhrig, T., Yang, S-H., ... Chen, C. M. (2017). A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice. Oncotarget, 8(5), 7357-7369. https://doi.org/10.18632/oncotarget.14458
Lai, Cheng Wei ; Chen, Hsiao Ling ; Tu, Min Yu ; Lin, Wei Yu ; Röhrig, Theresa ; Yang, Shang-Hsun ; Lan, Ying Wei ; Chong, Kowit Yu ; Chen, Chuan Mu. / A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice. In: Oncotarget. 2017 ; Vol. 8, No. 5. pp. 7357-7369.
@article{3576ebe3191c4a36915486389801f749,
title = "A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice",
abstract = "The AKR1A1 protein is a member of the aldo-keto reductase superfamily that is responsible for the conversion of D-glucuronate to L-gulonate in the ascorbic acid (vitamin C) synthesis pathway. In a pCAG-eGFP transgenic mouse line that was produced by pronuclear microinjection, the integration of the transgene resulted in a 30-kb genomic DNA deletion, including the Akr1A1 gene, and thus caused the knockout (KO) of the Akr1A1 gene and targeting of the eGFP gene. The Akr1A1 KO mice (Akr1A1eGFP/eGFP) exhibited insufficient serum ascorbic acid levels, abnormal bone development and osteoporosis. Using micro-CT analysis, the results showed that the microarchitecture of the 12-week-old Akr1A1eGFP/eGFP mouse femur was shorter in length and exhibited less cortical bone thickness, enlargement of the bone marrow cavity and a complete loss of the trabecular bone in the distal femur. The femoral head and neck of the proximal femur also showed a severe loss of bone mass. Based on the decreased levels of serum osteocalcin and osteoblast activity in the Akr1A1eGFP/ eGFP mice, the osteoporosis might be caused by impaired bone formation. In addition, administration of ascorbic acid to the Akr1A1eGFP/eGFP mice significantly prevented the condition of osteoporotic femurs and increased bone formation. Therefore, through ascorbic acid administration, the Akr1A1 KO mice exhibited controllable osteoporosis and may serve as a novel model for osteoporotic research.",
author = "Lai, {Cheng Wei} and Chen, {Hsiao Ling} and Tu, {Min Yu} and Lin, {Wei Yu} and Theresa R{\"o}hrig and Shang-Hsun Yang and Lan, {Ying Wei} and Chong, {Kowit Yu} and Chen, {Chuan Mu}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.14458",
language = "English",
volume = "8",
pages = "7357--7369",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "5",

}

Lai, CW, Chen, HL, Tu, MY, Lin, WY, Röhrig, T, Yang, S-H, Lan, YW, Chong, KY & Chen, CM 2017, 'A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice', Oncotarget, vol. 8, no. 5, pp. 7357-7369. https://doi.org/10.18632/oncotarget.14458

A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice. / Lai, Cheng Wei; Chen, Hsiao Ling; Tu, Min Yu; Lin, Wei Yu; Röhrig, Theresa; Yang, Shang-Hsun; Lan, Ying Wei; Chong, Kowit Yu; Chen, Chuan Mu.

In: Oncotarget, Vol. 8, No. 5, 01.01.2017, p. 7357-7369.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice

AU - Lai, Cheng Wei

AU - Chen, Hsiao Ling

AU - Tu, Min Yu

AU - Lin, Wei Yu

AU - Röhrig, Theresa

AU - Yang, Shang-Hsun

AU - Lan, Ying Wei

AU - Chong, Kowit Yu

AU - Chen, Chuan Mu

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The AKR1A1 protein is a member of the aldo-keto reductase superfamily that is responsible for the conversion of D-glucuronate to L-gulonate in the ascorbic acid (vitamin C) synthesis pathway. In a pCAG-eGFP transgenic mouse line that was produced by pronuclear microinjection, the integration of the transgene resulted in a 30-kb genomic DNA deletion, including the Akr1A1 gene, and thus caused the knockout (KO) of the Akr1A1 gene and targeting of the eGFP gene. The Akr1A1 KO mice (Akr1A1eGFP/eGFP) exhibited insufficient serum ascorbic acid levels, abnormal bone development and osteoporosis. Using micro-CT analysis, the results showed that the microarchitecture of the 12-week-old Akr1A1eGFP/eGFP mouse femur was shorter in length and exhibited less cortical bone thickness, enlargement of the bone marrow cavity and a complete loss of the trabecular bone in the distal femur. The femoral head and neck of the proximal femur also showed a severe loss of bone mass. Based on the decreased levels of serum osteocalcin and osteoblast activity in the Akr1A1eGFP/ eGFP mice, the osteoporosis might be caused by impaired bone formation. In addition, administration of ascorbic acid to the Akr1A1eGFP/eGFP mice significantly prevented the condition of osteoporotic femurs and increased bone formation. Therefore, through ascorbic acid administration, the Akr1A1 KO mice exhibited controllable osteoporosis and may serve as a novel model for osteoporotic research.

AB - The AKR1A1 protein is a member of the aldo-keto reductase superfamily that is responsible for the conversion of D-glucuronate to L-gulonate in the ascorbic acid (vitamin C) synthesis pathway. In a pCAG-eGFP transgenic mouse line that was produced by pronuclear microinjection, the integration of the transgene resulted in a 30-kb genomic DNA deletion, including the Akr1A1 gene, and thus caused the knockout (KO) of the Akr1A1 gene and targeting of the eGFP gene. The Akr1A1 KO mice (Akr1A1eGFP/eGFP) exhibited insufficient serum ascorbic acid levels, abnormal bone development and osteoporosis. Using micro-CT analysis, the results showed that the microarchitecture of the 12-week-old Akr1A1eGFP/eGFP mouse femur was shorter in length and exhibited less cortical bone thickness, enlargement of the bone marrow cavity and a complete loss of the trabecular bone in the distal femur. The femoral head and neck of the proximal femur also showed a severe loss of bone mass. Based on the decreased levels of serum osteocalcin and osteoblast activity in the Akr1A1eGFP/ eGFP mice, the osteoporosis might be caused by impaired bone formation. In addition, administration of ascorbic acid to the Akr1A1eGFP/eGFP mice significantly prevented the condition of osteoporotic femurs and increased bone formation. Therefore, through ascorbic acid administration, the Akr1A1 KO mice exhibited controllable osteoporosis and may serve as a novel model for osteoporotic research.

UR - http://www.scopus.com/inward/record.url?scp=85018862263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018862263&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.14458

DO - 10.18632/oncotarget.14458

M3 - Article

AN - SCOPUS:85018862263

VL - 8

SP - 7357

EP - 7369

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 5

ER -